Adendra Therapeutics raised €47M in a Series A round in Dec 2021. The company is based in London, UK. Investors in the round: ATP. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
